3-Dimensional Pharma Receives Patent for High-Throughput Technology | GenomeWeb


XTON, Pa.--3-Dimensional Pharmaceuticals has received its second patent on a method for getting quantitative measurements of drug-binding affinity to almost any protein or nucleic acid target--a technology the company calls ThermoFluor. The first patent, announced earlier this year, covered the assay methodology while the new patent covers the assay apparatus.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.